Literature DB >> 17698858

Mining complex genotypic features for predicting HIV-1 drug resistance.

Hiroto Saigo1, Takeaki Uno, Koji Tsuda.   

Abstract

MOTIVATION: Human immunodeficiency virus type 1 (HIV-1) evolves in human body, and its exposure to a drug often causes mutations that enhance the resistance against the drug. To design an effective pharmacotherapy for an individual patient, it is important to accurately predict the drug resistance based on genotype data. Notably, the resistance is not just the simple sum of the effects of all mutations. Structural biological studies suggest that the association of mutations is crucial: even if mutations A or B alone do not affect the resistance, a significant change might happen when the two mutations occur together. Linear regression methods cannot take the associations into account, while decision tree methods can reveal only limited associations. Kernel methods and neural networks implicitly use all possible associations for prediction, but cannot select salient associations explicitly.
RESULTS: Our method, itemset boosting, performs linear regression in the complete space of power sets of mutations. It implements a forward feature selection procedure where, in each iteration, one mutation combination is found by an efficient branch-and-bound search. This method uses all possible combinations, and salient associations are explicitly shown. In experiments, our method worked particularly well for predicting the resistance of nucleotide reverse transcriptase inhibitors (NRTIs). Furthermore, it successfully recovered many mutation associations known in biological literature. AVAILABILITY: http://www.kyb.mpg.de/bs/people/hiroto/iboost/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698858     DOI: 10.1093/bioinformatics/btm353

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  9 in total

1.  Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance.

Authors:  Jing Zhang; Tingjun Hou; Wei Wang; Jun S Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

2.  Extracting causal relations on HIV drug resistance from literature.

Authors:  Quoc-Chinh Bui; Breanndán O Nualláin; Charles A Boucher; Peter M A Sloot
Journal:  BMC Bioinformatics       Date:  2010-02-23       Impact factor: 3.169

Review 3.  Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem.

Authors:  Ge-Fei Hao; Guang-Fu Yang; Chang-Guo Zhan
Journal:  Drug Discov Today       Date:  2012-07-10       Impact factor: 7.851

4.  Predicting drug resistance of the HIV-1 protease using molecular interaction energy components.

Authors:  Tingjun Hou; Wei Zhang; Jian Wang; Wei Wang
Journal:  Proteins       Date:  2009-03

5.  Dynamical basis for drug resistance of HIV-1 protease.

Authors:  Yi Mao
Journal:  BMC Struct Biol       Date:  2011-07-08

6.  Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors.

Authors:  Muhammad Junaid; Maris Lapins; Martin Eklund; Ola Spjuth; Jarl E S Wikberg
Journal:  PLoS One       Date:  2010-12-15       Impact factor: 3.240

7.  A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.

Authors:  Kathleen M Doherty; Priyanka Nakka; Bracken M King; Soo-Yon Rhee; Susan P Holmes; Robert W Shafer; Mala L Radhakrishnan
Journal:  BMC Bioinformatics       Date:  2011-12-15       Impact factor: 3.169

8.  An interpretable machine learning model for diagnosis of Alzheimer's disease.

Authors:  Diptesh Das; Junichi Ito; Tadashi Kadowaki; Koji Tsuda
Journal:  PeerJ       Date:  2019-03-01       Impact factor: 2.984

9.  Discovering combinatorial interactions in survival data.

Authors:  David A Duverle; Ichiro Takeuchi; Yuko Murakami-Tonami; Kenji Kadomatsu; Koji Tsuda
Journal:  Bioinformatics       Date:  2013-09-13       Impact factor: 6.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.